Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bill Fixes 340B Discounts For Orphan Drugs In Children's Hospitals; Will More Entities Follow?

This article was originally published in The Pink Sheet Daily

Executive Summary

"Doc fix" bill to delay Medicare cuts in physician pay also says children's hospitals can get 340B discounts on orphan drugs - but some manufacturers are already dropping those discounts.

You may also be interested in...



Energy And Commerce Committee Chair Upton Is Orphan Drug Advocate

Newly-selected House Energy and Commerce Committee Chairman Fred Upton, R-Mich., brings a commitment to orphan drug development to his new role.

340B Entities Will Continue Fighting For Inpatient Drug Discounts

Issue is a top priority for Safety Net Hospitals for Pharmaceutical Access; provision to extend discounts to inpatient drugs was deleted from final health care reform bill.

GSK's Nucala Is Significantly Overpriced, ICER Draft Report Finds

New biologic for severe asthma doesn't stack up well to standard of care on generally accepted levels of cost per quality-adjusted life year.

Topics

UsernamePublicRestriction

Register

LL1133833

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel